Fig. 1 (abstract P538).
From: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)
Decrease in calprotectin values after vedolizumab/infliximab therapy according to time from onset to treatment initiation